Skip to main content

For informational and research purposes only.

Medical DisclaimerTerms of Use

Slippery Elm: The Definitive Guide

The inner bark forms mucilage, but no controlled trial establishes that slippery elm alone treats reflux, IBS or a digestive disease.

Traditional demulcent use is plausible; results from multi-ingredient formulas cannot isolate slippery elm’s effect.
Published by DoserlyUpdated Next scheduled review: January 20277 min readHow this guide was made
In this guide

What is slippery elm?

Slippery elm (Ulmus rubra) is a North American tree. Its inner bark contains polysaccharides that swell in water and form a viscous mucilage. That physical property explains its traditional use as a throat and digestive demulcent; it does not establish disease treatment.

Capsules, powders, lozenges and concentrated extracts do not create the same exposure. Keep the Latin name, plant part, extraction ratio and dried-bark equivalent attached to the exact product.

Typical Slippery Elm Protocols

Source-described exposures, not personal recommendations. The 2010 multi-ingredient study permits no slippery-elm attribution. [1]–[3]
Source and contextMaterialAmountFrequencyDurationObserved result
Hawrelak 2010 · IBSSlippery elm bark within two multi-ingredient formulasNot reported in abstractNot reported in abstractNot reported in abstractWithin-group improvement in some symptoms
31 people; open-label and uncontrolled. Co-ingredients differed by IBS subtype, so no slippery-elm effect can be estimated.
LiverTox 2024 · liver safetySlippery elm preparationsVariableVariableVariableNo published liver-injury signal
Absence of a signal does not establish digestive efficacy or the safety of every commercial product.
Licensed Canadian product · regulatory example10:1 dry inner-bark extract400 mg, equivalent to 4000 mg dried barkOnce dailyPer labelLicensed traditional demulcent use
One specific NPN example, not a universal dose or evidence that products are equivalent.

No RDA, AI or UL exists for slippery elm. Do not confuse extract mass with its dried-bark equivalent.

Identity
Record Ulmus rubra, inner bark and extraction ratio.
Actual amount
Separate extract mass from dried-bark equivalent.
Timing
Document the interval from medicines and meals.
Outcomes
Track the target symptom, stool pattern, pain, allergy and discontinuation.
From mucilage to clinical claim
1 · MATERIAL

Inner bark

Ulmus rubra, verifiable species and plant part.

→
2 · EXPOSURE

Hydrated gel

Polysaccharides swell and create viscous local contact.

→
3 · EVIDENCE

Attribution missing

Human data use blends; no ingredient-specific effect is estimable.

A plausible physical property does not replace a controlled single-ingredient trial.
Mucilage supports plausible local contact, while human evidence does not establish an ingredient-specific clinical effect. Sources: Hawrelak 2010 · LiverTox.

What is slippery elm commonly used for?

Common uses include sore throat, reflux, dyspepsia, constipation and IBS. These uses rest mainly on tradition, mucilage texture and finished-product experience. None has robust controlled-trial evidence for slippery elm alone.

Persistent symptoms or those accompanied by trouble swallowing, bleeding, anemia, weight loss, vomiting, fever or severe pain need clinical assessment.

Which forms and labels matter?

Look for Ulmus rubra, inner bark, mass per serving, extraction ratio and dried-material equivalent, plus an NPN in Canada. A lozenge holds material in the mouth; hydrated powder forms a gel; a capsule releases after dissolution. These forms are not interchangeable.

What does the human evidence show?

Hawrelak and Myers studied 31 adults meeting Rome II IBS criteria. Twenty-one received a formula containing bilberry, slippery elm, agrimony and cinnamon; ten received a formula containing slippery elm, lactulose, oat bran and licorice. Some symptoms improved from baseline, but there was no placebo, blinding or slippery-elm-only group. [1]

LiverTox states that slippery elm has not been linked to liver-enzyme elevations or clinically apparent liver injury. That liver-safety conclusion does not answer digestive efficacy, absorption-interaction or product-contamination questions. [2]

The Canadian database shows that one specific product, 400 mg of a 10:1 dry extract equivalent to 4 g dried bark once daily, is licensed for traditional demulcent use. This describes product authorization, not an efficacy trial. [3]

How might it work?

Polysaccharides absorb water and form a viscous gel. The gel may increase contact time with mucosal surfaces and change the texture of intestinal contents. Observed viscosity, however, does not prove reduced reflux, inflammation or pain.

What are the risks and interactions?

Abdominal discomfort, constipation, looser stools or allergy are possible. Avoid self-treatment with bowel obstruction or difficulty swallowing. Botanical quality matters because outer bark and other elm species are not equivalent to U. rubra inner bark.

Mucilage may theoretically delay or reduce absorption of an oral medicine. No study defines a universal interval; ask a pharmacist, especially for narrow-therapeutic-index medicines. Pregnancy, breastfeeding and pediatric use need professional review because data are sparse.

Status in the United States and Canada

In the United States, a slippery elm supplement is not an approved drug for reflux or IBS. In Canada, uses and doses are specific to the licensed product; verify the NPN and cautions.

What should be monitored?

Record product and lot, form, extract mass, dried-material equivalent, water used, medicine interval, target symptom, stool pattern, pain, allergy and reason for stopping.

What happens after stopping?

No withdrawal syndrome or taper is established. If the product changed stool texture or throat sensation, that local effect may disappear after stopping.

How should it be stored?

Keep bark dry, sealed and away from heat and moisture. Discard powder with changed odor, color or texture and retain the lot number.

Community experiences

Anecdotes often use “slippery elm” without species, plant part, water amount or co-ingredients. Immediate soothing describes local contact; it does not prove disease healing.

How does it compare with other approaches?

Reflux, IBS, constipation and sore throat have different causes and treatments. Slippery elm is a traditional demulcent with very limited ingredient-specific evidence; it does not replace diagnosis, appropriate dietary measures or proven treatments.

Frequently asked questions

Is there a slippery-elm-only trial?

No single-ingredient controlled trial for reflux, sore throat or IBS was located in this review.

Does the 2010 study prove benefit?

No. It was open-label, uncontrolled and used two different mixtures. [1]

Does a 10:1 extract mean 4 g per capsule?

In the Canadian example, 400 mg extract corresponds to 4000 mg dried bark; they are different measures. [3]

Should it be separated from medicines?

Prudently, yes, but no trial defines a universal interval. Confirm with a pharmacist.

Is it safe for the liver?

LiverTox reports no slippery-elm liver-injury signal, but that does not guarantee every product. [2]

Glossary

Terms used in this guide.

Mucilage
Plant polysaccharides that swell in water and form a gel.
Demulcent
Material intended to soothe by local contact and coating.
Inner bark
Living tissue beneath outer bark; the traditionally used plant part.
Extraction ratio
Ratio of starting botanical material to resulting extract.
Attribution
Ability to connect an outcome to one specific ingredient.

How this guide was researched

This guide prioritizes the only located directly relevant human study, the LiverTox summary and a verifiable Canadian regulatory example. Searches and source identities were checked October 9, 2026.

How this guide was made

Method and evidence gaps

PubMed records were checked for title, authors, journal, DOI and correction fields. The 2010 abstract supplies design, participant count, co-ingredients and results, but not the exact administration schedule. LiverTox supplies the liver-safety conclusion. The Health Canada database supplies dose and ratio for one specific product.

Gaps: single-ingredient controlled trials, dose response, medicine absorption, pregnancy, breastfeeding, pediatrics and long-term safety.

Sources

Start with the human study, then inspect the safety summary and Canadian regulatory example.

Showing 3 sources

  1. 01

    Effects of two natural medicine formulations on irritable bowel syndrome symptoms: a pilot study. ↗

    Open-label uncontrolled pilot study

    31 people; two multi-ingredient formulas; no slippery-elm-specific effect can be estimated.

  2. 02

    Slippery Elm ↗

    Institutional liver-safety summary

    No reported link to liver-enzyme elevations or clinically apparent liver injury.

  3. 03

    Licensed Natural Health Product: Slippery Elm Bark, NPN 80139278 ↗

    Licensed-product regulatory record

    10:1 dry extract, 400 mg once daily, equivalent to 4000 mg dried bark; licensed traditional demulcent use.